Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
Links shared publicly online about this topic.
- 773total visits
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the Oct. 27 issue of JAMA.
View full resource at eurekalert.org
Tags: Heart, Genetic, Drug, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on October 26, 2010 at 9:34 pm By:
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures: ( JAMA and Arc... http://bit.ly/94oABn
Advertisement
